Should Prediabetes Be Treated With GLP-1 Drugs? The Case For and Against Early Intervention | Research

The takeaway

Comprehensive review of prediabetes treatment options examines the evidence for GLP-1 drugs in preventing progression to type 2 diabetes, weighing benefits against cost and lifelong treatment concerns.

Prevent diabetes?
GLP-1 drugs could potentially prevent prediabetes from progressing to T2D, but treating hundreds of millions raises cost and feasibility questions

What the researchers found

GLP-1 drugs can effectively treat prediabetes and potentially prevent T2D progression, but cost, lifelong treatment necessity, and population-level feasibility remain major barriers.

Why it matters

Treating prediabetes could prevent millions of diabetes cases. But prescribing expensive GLP-1 drugs to hundreds of millions of prediabetes patients raises cost and practicality concerns. Finding the right patients for early treatment is critical.

The numbers in context

Prediabetes defined as: IFG, IGT, or HbA1c 5.7-6.4%. Progression to T2DM occurs at 5-10% per year.

How the study worked

Comprehensive review of prediabetes pathophysiology, natural history, and treatment evidence including lifestyle intervention, metformin, and GLP-1 receptor agonists.

Who was studied

Adults with prediabetes (IFG, IGT, or HbA1c 5.7-6.4%)

What this study cannot tell us

Long review covering a broad topic. Evidence for GLP-1 drugs specifically in prediabetes is more limited than in diabetes. Cost-effectiveness analyses for prediabetes treatment are evolving.

How to read the evidence

Moderate evidence: comprehensive review with strong diabetes prevention rationale but limited prediabetes-specific GLP-1 trial data.

When this study was published

Published in 2025. Addresses one of the most consequential questions in metabolic medicine.

The bigger picture

The question of when to start GLP-1 drugs — at diabetes diagnosis, at prediabetes, or even earlier for prevention — is one of the most consequential in metabolic medicine. The answer will determine healthcare spending for decades and affect billions of lives.

Questions still open

Which prediabetes patients benefit most from GLP-1 drug treatment?
Would short-course GLP-1 treatment during prediabetes permanently prevent diabetes progression?
How does lifestyle modification compare to GLP-1 drugs for prediabetes in head-to-head studies?

Common questions

Should I take GLP-1 drugs for prediabetes?

It depends on your risk level. Lifestyle changes (diet, exercise, weight loss) are first-line and very effective. For high-risk individuals who cannot achieve adequate lifestyle modification, GLP-1 drugs may be considered. Discuss with your doctor based on your specific risk factors.

Can prediabetes be reversed without drugs?

Yes — lifestyle modification (losing 5-7% body weight through diet and exercise) reduces diabetes risk by ~58%. For many people, this is sufficient. GLP-1 drugs may be added for those who need additional support, particularly those with obesity or rapidly declining beta-cell function.

Read the original research

Prediabetes: To Be Treated or Not?

The Journal of the Association of Physicians of India, 73(10), 96-98

View on PubMed ↗Publisher’s paper ↗

Citation

Agrawal, Rajesh. (2025). Prediabetes: To Be Treated or Not?. The Journal of the Association of Physicians of India, 73(10), 96-98. https://doi.org/10.59556/japi.73.1172